Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies
Authors:
- 8 October 2007
- journal article
- review article
- Published by Wiley in Anaesthesia
- Vol. 62 (11) , 1154-1160
Abstract
Summary: We propose recommendations to reduce the risk of haemorrhagic events associated with regional anaesthesia in patients treated with newer anticoagulants after orthopaedic surgery. The risk/benefit ratio should be individualised for each patient according to the type and dose of anticoagulant, the type of regional anaesthesia and patient risk factors. Neuraxial anaesthetic management strategy can be based on the pharmacokinetic properties of specific anticoagulants, including the time required to reach maximal concentration, half‐life, and dose regimen. Central neuraxial blocks should not be performed and epidural catheters should not be removed until at least two half‐lives after the last injection of anticoagulant, the half‐life depending on renal function. After removing a catheter or after a haemorrhagic puncture, the timing of the next anticoagulant injection should be based on the time required for an anticoagulant dose to reach maximum activity. Vigilance remains paramount during the initial days after removal of a neuraxial catheter.Keywords
This publication has 33 references indexed in Scilit:
- Major complications of epidural analgesia after surgery: results of a six‐year surveyAnaesthesia, 2007
- Venous thromboembolism prevention in surgery and obstetricsEuropean Journal of Anaesthesiology, 2006
- Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE studyJournal of Thrombosis and Haemostasis, 2005
- Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerationsAnaesthesia, 2004
- Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe*Transfusion, 2003
- The Pharmacokinetics of Fondaparinux Sodium in Healthy VolunteersClinical Pharmacokinetics, 2002
- Impaired haemostasisd and regional anaesthesiaCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1996
- Anticoagulants and Spinal-Epidural AnesthesiaAnesthesia & Analgesia, 1994
- Mortality after spinal and general anaesthesia for surgical fixation of hip fracturesAnaesthesia, 1994
- Anesthetic Techniques during Surgical Repair of Femoral Neck FracturesAnesthesiology, 1992